Tag Archives: (BSX)

When The Market Gives Back What It Once Took Away

If Wall Street had a confessional booth, I’d be first in line. “Forgive me, market gods, for I underestimated how quickly sentiment could shift.” When I last wrote about Abbott Laboratories (ABT), the market was treating this medical device powerhouse like last week’s leftovers—despite growth that would make most CEOs weep with joy. Fast forward […]